Health
Persistent immune thrombocytopaenic purpura associated with SARS‐CoV‐2 infection – Wiley
Click on the article title to read more.
We describe evolution of persistent immune thrombocytopaenic purpura (ITP) from acute ITP in a young woman with clinically otherwise inapparent severe acute respiratory syndrome coronavirus 2 (SARSCoV2) infection (COVID19); her development of ITP was matter for an earlier report.[1] ITP is an acquired disease in which thrombocytopaenia results from autoantibodies against platelet antigens. Approximately 10% of patients with acute ITP develop persistent (lasting 312 months) or chronic (>12 months)…
-
General23 hours agoFederal Labor makes $100m Canberra convention centre funding pledge for planning, new aquatic centre
-
Noosa News7 hours agoNSW farmer calls for hunting buffer zones after bullets hit property
-
General17 hours agoLiberals dump NSW candidate who said women should not serve in ADF combat
-
General4 hours agoTasmanian amputees struggling to access local services and support